| human | 遺伝子名 | CHRNA6 |
| 同義語(エイリアス) | CHNRA6; cholinergic receptor, nicotinic, alpha 6 | |
| SWISS-PROTのID | SWISS-PROT:Q15825 | |
| EntrezGeneのID | EntrezGene:8973 | |
| その他のDBのID | HGNC:15963 |
| mouse | 遺伝子名 | Chrna6 |
| 同義語(エイリアス) | Acra6; Nica6; alpha6 nAChR | |
| SWISS-PROTのID | SWISS-PROT:Q9R0W9 | |
| EntrezGeneのID | EntrezGene:11440 | |
| その他のDBのID | MGI:106213 |
| rat | 遺伝子名 | Chrna6 |
| 同義語(エイリアス) | Acra6 | |
| SWISS-PROTのID | SWISS-PROT:P43143 | |
| EntrezGeneのID | EntrezGene:81721 | |
| その他のDBのID | RGD:69281 |
本文中に表示されているデータベースの説明
出典:Wikipedia
出典:『Wikipedia』 (2010/12/06 22:06 UTC 版)
Cholinergic receptor, nicotinic, alpha 6, also known as CHRNA6, is a human gene, which codes for the α6 subunit found in certain types of nicotinic acetylcholine receptors found primarily in the brain. Neural nicotinic acetylcholine receptors containing α6 subunits are expressed on dopamine-releasing neurons in the midbrain, and dopamine release following activation of these neurons is thought to be involved in the addictive properties of nicotine. Due to their selective localisation on dopaminergic neurons, α6-containing nACh receptors have also been suggested as a possible therapeutic target for the treatment of Parkinson's disease.